|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 217/74 | |
| A61K 31/138 | |||
| A61P 3/00 | |||
| A61P 25/00 |
| (11) | Number of the document | 2531485 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11740324.6 |
| Date of filing the European patent application | 2011-02-03 | |
| (97) | Date of publication of the European application | 2012-12-12 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/023535 |
| Date | 2011-02-03 |
| (87) | Number | WO 2011/097336 |
| Date | 2011-08-11 |
| (30) | Number | Date | Country code |
| 301441 P | 2010-02-04 | US |
| (72) |
KOZIKOWSKI, Alan, US
ROTH, Bryan, US
SVENNEBRING, Andreas, US
CHEN, Gang, US
CHO, Sung, Jin, KR
|
| (73) |
The Board of Trustees of the University of Illinois,
352 Henry Administration Building 506 South Wright Street, Urbana, IL 61801,
US
The University of North Carolina at Chapel Hill, 222 East Cameron Avenue 308 Bynum Hall Campus Box 4105, Chapel Hill, NC 27599-4105, US |
| (54) | HIGHLY SELECTIVE 5-HT(2C) RECEPTOR AGONISTS HAVING ANTAGONIST ACTIVITY AT THE 5-HT(2B) RECEPTOR |
| HIGHLY SELECTIVE 5-HT(2C) RECEPTOR AGONISTS HAVING ANTAGONIST ACTIVITY AT THE 5-HT(2B) RECEPTOR |